Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Return on Sales (2017 - 2025)

Selectis Health's Return on Sales history spans 14 years, with the latest figure at 0.12% for Q4 2025.

  • Quarterly results put Return on Sales at 0.12% for Q4 2025, down 29.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (down 1.0% YoY), and the annual figure for FY2025 was 0.02%, up 4.0%.
  • Return on Sales for Q4 2025 was 0.12% at Selectis Health, down from 0.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.17% in Q4 2024 to a low of 0.4% in Q4 2023.
  • The 5-year median for Return on Sales is 0.13% (2025), against an average of 0.12%.
  • The sharpest move saw Return on Sales plummeted -33bps in 2023, then soared 57bps in 2024.
  • Year by year, Return on Sales stood at 0.19% in 2021, then dropped by -6bps to 0.21% in 2022, then tumbled by -94bps to 0.4% in 2023, then soared by 143bps to 0.17% in 2024, then tumbled by -170bps to 0.12% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.12%, 0.05%, and 0.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.